BBC3 and glioblastoma: EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity. This function of EGFR/EGFRvIII leads to tumor drug resistance of glioblastoma.